Researchers are:
Even though only a small percentage of cancer survivors develop second malignancies, everyone who has had cancer must:
Improved long-term cancer survival rates have increased concern about the physical and psychological effects of the disease and the treatments used to cure it.
Doctors must monitor cancer patients carefully to make sure radiation and chemotherapy dosages low enough to eliminate unwanted side effects are strong enough to eradicate all a patient's cancer cells.
A patient who has had cancer should be aware of the risk of developing a second cancer. However, patients should not refuse or discontinue treatment for fear of developing a second malignancy. The benefits of cancer treatment far outweigh the risk of developing a new cancer.
Division of Cancer Control and Population Sciences, National Cancer Institute. 6130 Executive Blvd., Executive Plaza North, Rockeville, MD 20852. (301) 594-6776. <http://dccps.nci.nih.gov/ocs>.
National Childhood Cancer Foundation. 440 E. Huntington Dr., PO Box 60012, Arcadia, CA 91066-6012. (800) 458-NCCF. <http://www.nccf.org/NCCF/Advocacy/program.asp>.
Key cancer statistics. National Cancer Institute. <http://search.nci.nih.gov/search97cgi/s97_cgi>.29 April 2001
Long-term follow-up study. University of Minnesota. 10 April 2001. <http://www.cancer.umn.edu/ltfu>.27 April 2001.
Platz, Elizabeth A., et al. Second cancers. Cancer medicine. <http://www.cancernetwork.com/canmed/ch188/188-0.htm>.
Maureen Haggerty
—A consequence of illness or therapy that becomes evident only after long-term patient monitoring.
—A new, abnormal growth of tissue. A neoplasm may be benign or malignant.
—A cancer that originates in an organ or tissue rather than in bone marrow or the lymph system.
|
|
Author Info: Maureen Haggerty, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Cancer, 2002 |